vs
Side-by-side financial comparison of Flywire Corp (FLYW) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $157.5M, roughly 1.3× Flywire Corp). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 0.0%, a 57.4% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $4.5M).
Flywire Corp is a global payment and receivables solutions provider serving core verticals including education, healthcare, travel, and B2B commerce. It offers secure cross-border payment processing, currency conversion, and workflow tools for organizations and payers worldwide.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
FLYW vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $157.5M | $207.8M |
| Net Profit | $33.0K | $119.2M |
| Gross Margin | — | — |
| Operating Margin | -0.6% | 52.2% |
| Net Margin | 0.0% | 57.4% |
| Revenue YoY | 34.0% | — |
| Net Profit YoY | 100.2% | 330.1% |
| EPS (diluted) | $0.01 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $157.5M | — | ||
| Q3 25 | $200.1M | $207.8M | ||
| Q2 25 | $131.9M | — | ||
| Q1 25 | $133.5M | — | ||
| Q4 24 | $117.5M | — | ||
| Q3 24 | $156.8M | $0 | ||
| Q2 24 | $103.7M | $0 | ||
| Q1 24 | $114.1M | $0 |
| Q4 25 | $33.0K | — | ||
| Q3 25 | $29.6M | $119.2M | ||
| Q2 25 | $-12.0M | — | ||
| Q1 25 | $-4.2M | — | ||
| Q4 24 | $-15.9M | — | ||
| Q3 24 | $38.9M | $-51.8M | ||
| Q2 24 | $-13.9M | $-52.8M | ||
| Q1 24 | $-6.2M | $-39.6M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 16.1% | 52.2% | ||
| Q2 25 | -6.8% | — | ||
| Q1 25 | -8.2% | — | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | 12.9% | — | ||
| Q2 24 | -15.2% | — | ||
| Q1 24 | -5.2% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 14.8% | 57.4% | ||
| Q2 25 | -9.1% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | 24.8% | — | ||
| Q2 24 | -13.4% | — | ||
| Q1 24 | -5.4% | — |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.23 | $1.33 | ||
| Q2 25 | $-0.10 | — | ||
| Q1 25 | $-0.03 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $0.30 | $-0.60 | ||
| Q2 24 | $-0.11 | $-0.68 | ||
| Q1 24 | $-0.05 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $355.0M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $835.2M | $1.1B |
| Total Assets | $1.3B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $355.0M | — | ||
| Q3 25 | $377.3M | $786.9M | ||
| Q2 25 | $274.2M | — | ||
| Q1 25 | $255.3M | — | ||
| Q4 24 | $611.1M | — | ||
| Q3 24 | $681.1M | $920.0M | ||
| Q2 24 | $571.0M | $701.7M | ||
| Q1 24 | $619.0M | $698.8M |
| Q4 25 | — | — | ||
| Q3 25 | $15.0M | — | ||
| Q2 25 | $60.0M | — | ||
| Q1 25 | $60.0M | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $835.2M | — | ||
| Q3 25 | $829.1M | $1.1B | ||
| Q2 25 | $792.4M | — | ||
| Q1 25 | $784.3M | — | ||
| Q4 24 | $814.8M | — | ||
| Q3 24 | $843.2M | $1.2B | ||
| Q2 24 | $802.6M | $931.7M | ||
| Q1 24 | $-797.0M | $935.3M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $998.7M | $973.7M | ||
| Q1 24 | $998.7M | $961.5M |
| Q4 25 | — | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.08× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.9M | $142.2M |
| Free Cash FlowOCF − Capex | $4.5M | $142.2M |
| FCF MarginFCF / Revenue | 2.9% | 68.4% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 148.06× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $98.8M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | — | ||
| Q3 25 | $150.1M | $142.2M | ||
| Q2 25 | $24.1M | — | ||
| Q1 25 | $-78.9M | — | ||
| Q4 24 | $-28.6M | — | ||
| Q3 24 | $184.6M | $-49.2M | ||
| Q2 24 | $-19.3M | $-32.9M | ||
| Q1 24 | $-38.1M | $-43.8M |
| Q4 25 | $4.5M | — | ||
| Q3 25 | $149.9M | $142.2M | ||
| Q2 25 | $23.5M | — | ||
| Q1 25 | $-79.1M | — | ||
| Q4 24 | $-28.7M | — | ||
| Q3 24 | $184.4M | $-49.7M | ||
| Q2 24 | $-19.7M | $-33.9M | ||
| Q1 24 | $-38.3M | $-45.1M |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 74.9% | 68.4% | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | -59.3% | — | ||
| Q4 24 | -24.4% | — | ||
| Q3 24 | 117.6% | — | ||
| Q2 24 | -19.0% | — | ||
| Q1 24 | -33.6% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 148.06× | — | ||
| Q3 25 | 5.07× | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.75× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FLYW
| Transactions | $126.4M | 80% |
| Platform And Other Revenues | $31.1M | 20% |
IDYA
Segment breakdown not available.
